Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
β-Agarase cleaves the β-1,4 linkages of agar to produce neoagarooligosaccharides (NAO), which are associated with various physiological functions. However, the immunological functions of NAO are still unclear. In this study, we demonstrated that β-agarase DagA-produced neoagarohexaose (DP6), an NAO product, promoted the maturation of dendritic cells (DCs) by Toll-like receptor 4 (TLR4). DP6 directly and indirectly enhanced the activation of natural killer (NK) cells in a TLR4-dependent manner in vitro and in vivo. Finally, the antitumor activity of DP6 against B16F1 melanoma cells was inhibited in NK cell-depletion systems by using NK-cell depleting antibodies in vivo. Collectively, the results indicated that DP6 augments antitumor immunity against B16F1 melanoma cells via the activation of DC-mediated NK cells in a TLR4-dependent manner. Thus, DP6 is a potential candidate adjuvant that acts as an immune cell modulator for the treatment of melanoma.
Abstract
β-Agarase cleaves the β-1,4 linkages of agar to produce neoagarooligosaccharides (NAO), which are associated with various physiological functions. However, the immunological functions of NAO are still unclear. In this study, we demonstrated that β-agarase DagA-produced neoagarohexaose (DP6), an NAO product, promoted the maturation of dendritic cells (DCs) by Toll-like receptor 4 (TLR4). DP6 directly and indirectly enhanced the activation of natural killer (NK) cells in a TLR4-dependent manner in vitro and in vivo. Finally, the antitumor activity of DP6 against B16F1 melanoma cells was inhibited in NK cell-depletion systems by using NK-cell depleting antibodies in vivo. Collectively, the results indicated that DP6 augments antitumor immunity against B16F1 melanoma cells via the activation of DC-mediated NK cells in a TLR4-dependent manner. Thus, DP6 is a potential candidate adjuvant that acts as an immune cell modulator for the treatment of melanoma.
참고문헌 (18)
- Temuujin U, "Overexpression and biochemical characterization of DagA from Streptomyces coelicolor A3(2): an endo-type beta-agarase producing neoagarotetraose and neoagarohexaose", Appl Microbiol Biotechnol, 92, pp.749~759 (2011)
- Fu XT, "Agarase: review of major sources, categories, purification method, enzyme characteristics and applications", Mar Drugs, 8, pp.200~218 (2010)
- Kono T, "Properties and Production of Neoagarooligosaccharides", J Agric Chem Soc Japan, 63, pp.1126~1129 (1989)
- Yoshizawa Y, "Macrophage stimulation activity of the polysaccharide fraction from a marine alga (Porphyra yezoensis): structurefunction relationships and improved solubility", Biosci Biotechnol Biochem, 59, pp.1933~1937 (1999)
- Lee SW, "Natural Killer Dendritic Cells Enhance Immune Responses Elicited by alpha-Galactosylceramide-Stimulated Natural Killer T Cells", Biomed Res Int, 2013, pp.460706~ (2013)
- Van Elssen CH, "Natural killer cells: the secret weapon in dendritic cell vaccination strategies", Clin Cancer Res, 20, pp.1095~1103 (2014)
- Raulet DH, "Interplay of natural killer cells and their receptors with the adaptive immune response", Nat Immunol, 5, pp.996~1002 (2004)
- Jung ID, "Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist", Cancer Res, 71, pp.2858~2870 (2011)
- Zhang X, "Toll-like receptor 2 and Toll-like receptor 4-dependent activation of B cells by a polysaccharide from marine fungus Phoma herbarum YS4108", PLoS One, 8, pp.e60781~ (2013)
- Park MJ, "Platycodon grandiflorum polysaccharide induces dendritic cell maturation via TLR4 signaling", Food Chem Toxicol, 72, pp.212~220 (2014)
- Terao H, "The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8＋ T cells and CD4＋ T cells", Immunobiology, 195, pp.172~186 (1996)
- Kalinski P, "Helper roles of NK and CD8＋ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines", Immunol Res, 36, pp.137~146 (2006)
- Aleem E, "beta-Glucans and their applications in cancer therapy: focus on human studies", Anticancer Agents Med Chem, 13, pp.709~719 (2013)
- Enoki T, "Oligosaccharides from agar inhibit pro-inflammatory mediator release by inducing heme oxygenase 1", Biosci Biotechnol Biochem, 74, pp.766~770 (2010)
- Karumuthil-Melethil S, "Fungal beta-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response", J Immunol, 193, pp.3308~3321 (2014)
- Cillo C, "Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines", Cancer Res, 47, pp.2604~2608 (1987)
- Wasser SP, "Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides", Appl Microbiol Biotechnol, 60, pp.258~274 (2002)
- Cheng WF, "CD8＋ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination", Gene Ther, 10, pp.1311~1320 (2003)